The Claim
Daily administration of GIP(3-42) for 14 days in obese diabetic ob/ob mice improved insulin sensitivity without changing plasma insulin concentrations, indicating that the improvement is mediated through extrapancreatic mechanisms.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese diabetic mice, daily injections of GIP(3-42) for 14 days increased insulin sensitivity without altering insulin levels in the blood, showing that the effect occurs through mechanisms outside the pancreas.
See the scientific wording
In obese diabetic ob/ob mice, daily GIP(3-42) administration for 14 days improved insulin sensitivity without altering plasma insulin concentrations, suggesting the effect is mediated through extrapancreatic mechanisms rather than enhanced insulin secretion.
A modified version of a gut hormone enters the bloodstream and acts on muscle and fat cells, making them take up more glucose from the blood without needing more insulin. This lowers blood sugar levels directly through improved tissue response to insulin.
What the research says
1 studyIn diabetic mice, a modified version of a gut hormone called GIP(3-42) helped the body use insulin better without making the pancreas produce more insulin — meaning it probably worked on muscles or fat instead.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.